Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY +4.34%94 Forward Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus rates PGNY with a GF Score™ of 94/100 and a GF Value™ of $28.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 9 Healthcare Plans companies, Progyny ranks worse than 11111100% on this metric.
As of today (2026-07-14), the Forward Annual Dividend Yield of Progyny is 0.00%.
As of today (2026-07-14), the Trailing Annual Dividend Yield of Progyny is 0.00%.
PGNY's Forward Dividend Yield % is not ranked *
in the Healthcare Plans industry.
Industry Median: 2.13 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
PGNY vs CLOV, PFHO, ALHC: Forward Dividend Yield % Comparison
For the Healthcare Plans subindustry, Progyny's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny Forward Dividend Yield % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Progyny's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Progyny (PGNY) has a Forward Dividend Yield % of 0.00% as of Jul. 14, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Progyny and its competitors. According to the industry distribution chart, Progyny ranks #999999 out of 9 companies in the Healthcare Plans industry.
Is Progyny's Forward Dividend Yield % too high?
Progyny's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Progyny ranks #999999 out of 9 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Progyny has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Forward Dividend Yield % compare to CLOV and PFHO?
According to the Healthcare Plans industry distribution chart, Progyny ranks #999999 out of 9 companies for Forward Dividend Yield %. This places Progyny in the lower half of its industry. The industry median Forward Dividend Yield % is 2.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Plans company?
The median Forward Dividend Yield % among Healthcare Plans companies is 2.13, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median Forward Dividend Yield % is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Modestly Overvalued. The stock's GF Value™ is $28.40, compared to a current price of $31.98 — trading 12.6% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Progyny's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Progyny (PGNY), the current Forward Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be overvalued.
The current stock price of $31.98 is trading 12.6% above its estimated GF Value™ of $28.40.
GuruFocus considers Progyny to be Modestly Overvalued.
Key valuation signals for PGNY:
Forward Dividend Yield %: 0.00%
GF Value™: $28.40 vs. price of $31.98 (12.6% above fair value)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
94GF Score
Get the complete analysis for PGNY
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
